Status:
COMPLETED
Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Venous Thrombosis (Disorder)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
VTE associated harm is underappreciated among hospitalized patients and may be associated with missed doses of VTE prophylaxis medications. In order to ensure best practices, and administer a defect-f...
Detailed Description
Missed doses of prescribed Venous Thromboembolism (VTE) pharmacologic prophylaxis is a significant problem. Data on patients admitted to The Johns Hopkins Hospital found approximately 12% of prescribe...
Eligibility Criteria
Inclusion
- Eligible floors are defined as:
- A. All medical and surgical floors (non- intensive care units) B. 16 total floors (10 medicine, 6 surgery)
- Eligible Patients are defined as: All patients on assigned floors except:
- A. Patient data for those transferred between floors will be excluded. B. Patient data for those on floors during the cross-over time will be excluded.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
9657 Patients enrolled
Trial Details
Trial ID
NCT03367364
Start Date
January 1 2018
End Date
November 1 2018
Last Update
March 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Medical Institutions
Baltimore, Maryland, United States, 21287